Danaher Corp
DHR
ISIN null / Valor 923916
Danaher Corp
UMushroom community rating:
About company
Danaher Corporation is a globally recognized conglomerate with a diverse portfolio that includes a significant presence in the biotechnology sector through its subsidiary, Cytiva. This segment of Danaher's business specializes in providing a comprehensive range of technologies, services, and expertise aimed at supporting the research, development, and manufacturing processes within the biopharmaceutical industry. Cytiva plays a crucial role in facilitating the advancement of therapeutics by offering solutions that enhance the safety and efficiency of developing and commercializing a wide array of medical treatments, including life-saving vaccines, biologic drugs, and innovative cell and gene therapies. Through its focus on innovation and customer support, Danaher, via Cytiva, contributes significantly to the progress of healthcare and the availability of advanced therapeutic options.
Summarized from source with an LLMView SourceSector: IndustrialsKey figures
Performance
Volatility
134427 M
Market cap (USD)
4,195,569
Daily traded volume (Shares)
230.56 / 227.58
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Celia Hänni
J V
EQUITIES OF THE SAME SECTOR
